{{knowledge objective
|Identifiant=OIC-177-12-B
|Item_parent=Prescription and monitoring of anti-infectives in adults and children (see item 330)
|Item_parent_short=Prescription and monitoring of anti-infectives in adults and children (see item 330)
|Rank=B
|Heading=Know (indications, contra-indications, spectrum, side-effects and interactions) the main macrolide molecules.
|Description=Erythromycin, spiramycin, clarithromycin, azithromycin
|Rubric=Definition
|Contributors=Jean-Philippe Lavigne
|Order=12}}

{| class="wikitable"
|'''Antibiotics'''
|'''Indications'''
|'''Contraindications'''
|'''Spectrum'''
|'''Side effects and interactions'''
|-
|'''Lincosamides'''

'''(molecule: clindamycin)''''
|Streptococcal angina in patients allergic to beta-lactam antibiotics, pneumonia caused by intracellular (including legionellosis) and atypical bacteria, whooping cough, skin infections, genital infections caused by Chlamydia trachomatis, certain Gram-negative bacillus infections (Salmonella, Shigella, Campylobacter), cat scratch disease, Toxoplasmosis in immunocompetent patients.
|Hypersensitivity to the active substance, to other macrolides or to one of the excipients, history of prolongation of the QT interval or ventricular arrhythmia, patients with electrolyte disorders.
|Intracellular bacteria, streptococci, meti-S staphylococci, Toxoplasma gondii, H. influenzae (species inconsistently susceptible).
|Enzyme inhibitors, nausea, vomiting, abdominal pain, allergic reactions, immunoallergic hepatitis, QT interval prolongation.


Interactions: very numerous; CYP3A4 inhibitors, ergot alkaloids, vasocontrictors, alfuzosin, astemizole, terfenadine, domperidone, cisapride, pimozide, colchicine, dapoxetine, ...
|}